FDA approves Tylenol with Naproxen as first OTC combo pain reliever
Go back to FDA approves Tylenol with Naproxen as first OTC combo pain reliever| (NYSE: KVUE) | Delayed: 17.93 +0.06 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.87 | 52 Week High | $ | |||
| Open | $17.80 | 52 Week Low | $ | |||
| Day High | $17.97 | P/E | N/A | |||
| Day Low | $17.76 | EPS | $ | |||
| Volume | 9,649,754 | |||||
